Veršeliai lt - Company finances
|
EUR
|
2021
From: 2021-08-19
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 43,957 | 40,236 | 79,970 | 51,297 | 96,987 |
| Profit before tax | 7,631 | -6,267 | 6,093 | 3,828 | -45 |
| Net profit | 7,631 | -6,267 | 5,814 | 3,715 | -45 |
| Equity | 7,632 | 1,365 | 7,179 | 10,894 | 10,849 |
| Liabilities | - | 11,080 | 3,655 | 10,174 | 97 |
| Non-current assets | 2,610 | 3,252 | 3,032 | 2,813 | 91 |
| Current assets | 31,018 | 9,193 | 7,802 | 18,255 | 10,855 |
| Total assets | 33,628 | 12,445 | 10,834 | 21,068 | 10,946 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 5,321 | 1,912 | 7,202 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | -8.5% | +98.8% | -35.9% | +89.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.7% | -50.4% | 53.7% | 17.6% | -0.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | -459.1% | 81.0% | 34.1% | -0.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.4% | -15.6% | 7.3% | 7.2% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 17.4% | -15.6% | 7.6% | 7.5% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 8.1 | 0.5 | 0.9 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,652 | 13,412 | 26,657 | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Veršeliai lt - Social security debts
The company had no debts to Sodra
Veršeliai lt - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biotechnologiniu tyrimu centras, MB (company code 305875140) is a small partnership operating in activities of agents involved in non-specialised wholesale. In the latest financial year, 2025, the company generated revenue of €97.0K, up 89.1% year on year and 21.3% over two years. Net profit for 2025 was -€45, leaving the company essentially at break-even after two profitable years. The business recorded net profit of €5.8K in 2023 and €3.7K in 2024, with revenue of €80.0K and €51.3K respectively, showing a dip in 2024 followed by a strong rebound in 2025. Total assets at the end of 2025 were €10.9K, broadly in line with equity of €10.8K, while liabilities were only €97. The 2025 equity ratio was 99.1% and debt-to-equity was 0.01, indicating very limited leverage. Asset turnover reached 8.86x, reflecting high revenue relative to the small asset base. Return on equity and return on assets were both -0.4% in 2025.